Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance study

Using data from a postmarketing surveillance, this interim subgroup analysis investigated the safety of sarilumab in younger (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Modern rheumatology 2024-12, Vol.35 (1), p.42-49
Hauptverfasser:	Kameda, Hideto, Tasaka, Sadatomo, Takahashi, Toshiya, Suzuki, Katsuhisa, Soeda, Naoki, van Hoogstraten, Hubert, Diab, Remco, Tanaka, Yoshiya
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antirheumatic Agents - adverse effects Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy East Asian People Female Humans Japan - epidemiology Male Middle Aged Product Surveillance, Postmarketing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Using data from a postmarketing surveillance, this interim subgroup analysis investigated the safety of sarilumab in younger (
ISSN:	1439-7595 1439-7609 1439-7609
DOI:	10.1093/mr/roae051